Patients treated with sugemalimab lived on average 9.0 months without disease progression, compared to 4.9 months in the placebo group
The Medicines and Healthcare products...
Pharmacies serve as vital hubs for health information and community support, making cancer awareness campaigns particularly impactful within these settings. By utilising professionally designed...
By 2038-2040, approximately 9,400 new cases of ovarian cancer are projected annually in the UK
Researchers at the University of Oxford have received a grant...
A 67-year-old lung cancer patient from London is the first to receive the vaccine at University College London Hospitals (UCLH)
A groundbreaking immunotherapy for non-small cell lung...